Atlas FDA

Surpass Evolve Flow Diverter System

FDA premarket approval P170024/S009 · decided 2021-07-12

Approval details

PMA number
P170024
Supplement
S009
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Surpass Evolve Flow Diverter System
Generic name
Intracranial aneurysm flow diverter
Applicant
Stryker Neurovascular
Date received
2021-06-30
Decision date
2021-07-12
Days to decision
12 days
Decision code
OK30
Product code
OUT
Advisory committee
Neurology
Expedited review
No
Location
Fremont, CA
Statement
Equipment relocation of the primary coil winders, used in the manufacturing and assembly of the Surpass Evolve Flow Diverter System, from their existing location in a Class 8 cleanroom to a Non-Controlled Environment Area (Non-CE) in the warehouse of Stryker’s manufacturing facility in Cork, Ireland.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Trevo Trak 21 Microcatheter (K261889)Stryker Neurovascular2026-07-01
AXS Lift Intracranial Base Catheter (K253032)Stryker Neurovascular2026-02-11
Target Detachable Coil (K252694)Stryker Neurovascular2025-12-11
InZone IST Detachment System; IZDS Connecting Cable (K251832)Stryker Neurovascular2025-10-17
Excelsior XT-27 Microcatheter, Excelsior XT-27 Flex Microcatheter, Excelsior XT-27 Pre-Shaped Microcatheter, Excelsior XT-27 Flex Pre-Shaped Microcatheter (K242289)Stryker Neurovascular2025-03-21
AXS Lift Intracranial Base Catheter (K243593)Stryker Neurovascular2025-02-18
Broadway 8 Catheter (K241768)Stryker Neurovascular2024-12-19
Echo Intracranial Base Catheter (K241637)Stryker Neurovascular2024-12-19